Astragaloside IV protects ATDC5 cells from lipopolysaccharide-caused damage through regulating miR-203/MyD88

Astragaloside IV protects ATDC5 cells from lipopolysaccharide-caused damage through regulating miR-203/MyD88

Context Osteoarthritis (OA) is a degenerative arthrosis sickness. Astragaloside IV (AS-IV) functions by relieving inflammatory damage. Objective We aimed to investigate the mechanism by which AS-IV protects ATD cells from lipopolysaccharide (LPS)-induced damage. Materials and methods ATDC5 cells wer...

Full description

Bibliographic Details
Main Authors: Dexin Li, Guangcheng Li, Yang Chen, Yifei Li, Junfeng Zhang, Dexuan Gao, Linglong Sun, Bo Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Pharmaceutical Biology
Subjects:
as-iv
inflammatory
osteoarthritis
Online Access:http://dx.doi.org/10.1080/13880209.2019.1705355

Internet

http://dx.doi.org/10.1080/13880209.2019.1705355

Similar Items